|
HEDIS 2011 NDC LISTS
|
|
Volume 2: Technical Specifications
|
|
NDC List and Volume 2 Table (.zip)
(Updated Nov. 15, 2010)
|
NDC List
(.zip)
|
Volume 2 Tables (zip).
|
|
NDC Summary of Changes (Updated Nov. 15, 2010) SummaryofChanges.pdf
|
|
|
NDC List
|
Volume 2 Table
|
|
Annual Monitoring for Patients on Persistent Medications (MPM)
|
|
|
|
Table MPM-B: Drugs to Identify Members on Digoxin
|
Table MPM-B.xls
|
Table MPM-B.doc
|
|
Table MPM-C: Drugs to Identify Members on Diuretics
|
Table MPM-C.xls
|
Table MPM-C.doc
|
|
Table MPM-D: Drugs to Identify Members on Anticonvulsants
|
Table MPM-D.xls
|
Table MPM-D.doc
|
|
Antibiotic Utilization (ABX)
|
|
|
|
Table ABX-A: Antibiotic Medications
|
Table ABX-A.xls
|
Table ABX-A.doc
|
|
Table ABX-B: Antibiotic of Concern by NCQA Drug Class
|
Table ABX-B.xls
|
Table ABX-B.doc
|
|
Table ABX-C: All Other Antibiotics by NCQA Drug Class
|
Table ABX-C.xls
|
Table ABX-C.doc
|
|
Antidepressant Medications Management (AMM)
|
|
|
|
Table AMM-D: Antidepressant Medications
|
Table AMM-D.xls
|
Table AMM-D.doc
|
|
Appropriate Treatment for Children with Pharyngitis (CWP)
|
|
|
|
Table CWP-C: Antibiotic Medications
|
Table CWP-C.xls
|
Table CWP-C.doc
|
|
Avoidance of Antibiotic Treatment for Adults with Acute Bronchitis (AAB)
|
|
|
|
Table AAB-D: Antibiotic Medications
|
Table AAB-D.xls
|
Table AAB-D.doc
|
|
Chlamydia Screening in Women (CHL)
|
|
|
|
Table CHL-A: Prescriptions to Identify Contraceptives
|
Table CHL-A.xls
|
Table CHL-A.doc
|
|
Table CHL-E: Medications to Identify Exclusions
|
Table CHL-E.xls
|
Table CHL-E.doc
|
|
Comprehensive Diabetes Care (CDC)
|
|
|
|
Table CDC-A/Table DCDC-A: Prescriptions to Identify Members with Diabetes
***Note: Because the same NDC list is used for both HEDIS reporting and Disease Management reporting, table names are listed for both products.
|
Table CDC-A/
Table DCDC-A.xls
|
Table CDC-A/ Table DCDC-A.doc
|
|
Table CDC-L/Table DCDC-P: ACE Inhibitors/ARBs
***Note: Because the same NDC list is used for both HEDIS reporting and Disease Management reporting, table names are listed for both products.
|
Table CDC-L/ Table DCDC-P.xls
|
Table CDC-L /Table DCDC-P.doc
|
|
Comprehensive Ischemic Vascular Disease Care
|
|
|
|
Table IVD-E: Oral Anti-Platelet Therapies
***Note: This table is only applicable to the Technical Specifications for Physician Measurement.
|
Table IVD-E.xls
|
Table IVD-E.doc
|
|
Disease Modifying Anti-Rheumatic Drug Therapy (ART)
|
|
|
|
Table ART-C: DMARDs
|
Table ART-C.xls
|
Table ART-C.doc
|
|
Follow-Up Care for Children Prescribed ADHD Medication (ADD)
|
|
|
|
Table ADD-A: ADHD Medications
|
Table ADD-A.xls
|
Table ADD-A.doc
|
|
Osteoporosis Management in Women Who had a Fracture (OMW)
|
|
|
|
Table OMW-C: FDA-Approved Osteoporosis Therapies
|
Table OMW-C.xls
|
Table OMW-C.doc
|
|
Persistence of BB Treatment After a Heart Attack (PBH)
|
|
|
|
Table PBH-B/Table DPBH-B: Beta-Blocker Medications
***Note: Because the same NDC list is used for both HEDIS reporting and Disease Management reporting, table names are listed for both products.
|
Table PBH-B/
Table DPBH-B.xls
|
Table PBH-B /
Table DPBH-B.doc
|
|
Table PBH-D/Table DPBH-D: Medications to Identify Exclusion (History of Asthma)
***Note: Because the same NDC list is used for both HEDIS reporting and Disease Management reporting, table names are listed for both products.
|
Table PBH-D/
Table DPBH-D.xls
|
Table PBH-D/
Table DPBH-D.doc
|
|
Pharmacotherapy Management of COPD Exacerbation (PCE)
|
|
|
|
Table PCE-C: Systemic Corticosteroids
|
Table PCE-C.xls
|
Table PCE-C.doc
|
|
Table PCE-D: Bronchodilators
|
Table PCE-D.xls
|
Table PCE-D.doc
|
|
Potentially Harmful Drug-Disease Interactions in the Elderly (DDE)
|
|
|
|
Table DDE-C: Tricyclic Antidepressants
|
Table DDE-C.xls
|
Table DDE-C.doc
|
|
Table DDE-D: Antipsychotics and Sleep Agents
|
Table DDE-D.xls
|
Table DDE-D.doc
|
|
Table DDE-F: Medications for Dementia
|
Table DDE-F.xls
|
Table DDE-F.doc
|
|
Table DDE-G: Anticholingeric Agents
|
Table DDE-G.xls
|
Table DDE-G.doc
|
|
Table DDE-I: NSAIDs and Cox-2 Selective NSAIDs
|
Table DDE-I.xls
|
Table DDE-I.doc
|
|
Use of Appropriate Medications for People with Asthma (ASM) (Updated Nov. 15, 2010)
|
|
|
|
Table ASM-C/Table DASM-C: Asthma Medications
***Note: Because the same NDC list is used for both HEDIS reporting and Disease Management reporting, table names are listed for both products.
|
Table ASM-C/
Table DASM-C.xls
|
Table ASM-CTableDASM-C.doc
|
|
Table ASM-D/Table DASM-D: Preferred Asthma Therapy Medications
***Note: Because the same NDC list is used for both HEDIS reporting and Disease Management reporting, table names are listed for both products.
|
Table ASM-D/
Table DASM-D.xls
|
Table ASM-D-Table DASM-D.doc
|
|
Use of High-Risk Medications in the Elderly (DAE)
|
|
|
|
Table DAE-A: High-Risk Medications
|
Table DAE-A.xls
|
Table DAE-A.doc
|